500 related articles for article (PubMed ID: 8969245)
1. New vaccines for the prevention of pneumococcal infections.
Käyhty H; Eskola J
Emerg Infect Dis; 1996; 2(4):289-98. PubMed ID: 8969245
[TBL] [Abstract][Full Text] [Related]
2. [Pneumococcal vaccination for children and adults].
Albrich W
Ther Umsch; 2016; 73(5):235-40. PubMed ID: 27268445
[TBL] [Abstract][Full Text] [Related]
3. [Value of pneumococcal vaccination in infants and young children].
Adam D; Scholz H
Klin Padiatr; 2001; 213(3):109-13. PubMed ID: 11417363
[TBL] [Abstract][Full Text] [Related]
4. Pneumococcal conjugate vaccine for young children.
Selman S; Hayes D; Perin LA; Hayes WS
Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
[TBL] [Abstract][Full Text] [Related]
5. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae.
Briles DE; Hollingshead SK; Nabors GS; Paton JC; Brooks-Walter A
Vaccine; 2000 Dec; 19 Suppl 1():S87-95. PubMed ID: 11163470
[TBL] [Abstract][Full Text] [Related]
6. Direct and indirect effects of the 13-valent pneumococcal conjugate vaccine administered to infants and young children.
Esposito S; Principi N;
Future Microbiol; 2015; 10(10):1599-607. PubMed ID: 26439470
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
Pavia M; Bianco A; Nobile CG; Marinelli P; Angelillo IF
Pediatrics; 2009 Jun; 123(6):e1103-10. PubMed ID: 19482744
[TBL] [Abstract][Full Text] [Related]
8. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.
O'Brien KL; Steinhoff MC; Edwards K; Keyserling H; Thoms ML; Madore D
Pediatr Infect Dis J; 1996 May; 15(5):425-30. PubMed ID: 8724065
[TBL] [Abstract][Full Text] [Related]
9. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
[TBL] [Abstract][Full Text] [Related]
10. Polysaccharide-based pneumococcal vaccines in the prevention of acute otitis media.
Eskola J
Vaccine; 2000 Dec; 19 Suppl 1():S78-82. PubMed ID: 11163468
[TBL] [Abstract][Full Text] [Related]
11. [Medical indications and effectiveness of the pneumococcal conjugate vaccine].
Reinert RR
Laryngorhinootologie; 2006 Apr; 85(4):291-8; quiz 299-300. PubMed ID: 16615030
[TBL] [Abstract][Full Text] [Related]
12. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.
Durando P; Faust SN; Fletcher M; Krizova P; Torres A; Welte T
Clin Microbiol Infect; 2013 Oct; 19 Suppl 1():1-9. PubMed ID: 24083785
[TBL] [Abstract][Full Text] [Related]
13. The cost-burden of paediatric pneumococcal disease in Sweden and the potential cost-effectiveness of prevention using 7-valent pneumococcal vaccine.
Silfverdal SA; Berg S; Hemlin C; Jokinen I
Vaccine; 2009 Mar; 27(10):1601-8. PubMed ID: 19146905
[TBL] [Abstract][Full Text] [Related]
14. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
[TBL] [Abstract][Full Text] [Related]
15. 7-valent pneumococcal conjugate vaccine: new preparation. Prevents rare invasive infections in infants.
Prescrire Int; 2002 Feb; 11(57):7-10. PubMed ID: 11985376
[TBL] [Abstract][Full Text] [Related]
16. Pneumococcal otitis media and pneumococcal vaccines, a historical perspective.
Austrian R
Vaccine; 2000 Dec; 19 Suppl 1():S71-7. PubMed ID: 11163467
[TBL] [Abstract][Full Text] [Related]
17. Use of pneumococcal polysaccharide vaccines: no simple answers.
French N
J Infect; 2003 Feb; 46(2):78-86. PubMed ID: 12634068
[TBL] [Abstract][Full Text] [Related]
18. The diversity of pneumococcal conjugate vaccine impact observed through their implementation.
Dagan R
Hum Vaccin Immunother; 2016; 12(2):266-7. PubMed ID: 26905677
[No Abstract] [Full Text] [Related]
19. Efficacy of a pneumococcal conjugate vaccine against acute otitis media.
Eskola J; Kilpi T; Palmu A; Jokinen J; Haapakoski J; Herva E; Takala A; Käyhty H; Karma P; Kohberger R; Siber G; Mäkelä PH;
N Engl J Med; 2001 Feb; 344(6):403-9. PubMed ID: 11172176
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal conjugate vaccine use in adults - Addressing an unmet medical need for non-bacteremic pneumococcal pneumonia.
Sings HL
Vaccine; 2017 Sep; 35(40):5406-5417. PubMed ID: 28602602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
